The Impact Of Nanoparticles In Biomaterials Of Human Health
Keywords:
N\AAbstract
Background: The move towards incorporating nanoparticles into biomaterials systems is mainly due to their specific physicochemical features which make them useful in drug delivery, wound healing, and even tissue engineering. The worries surrounding their possible health risks such as toxicity, immune reactions, and bioaccumulation have raised attention from all sectors of society and science to intensify scrutiny. The perception and trust of society in the safety of nanoparticles in biomaterials need to be understood to enable focused risk communication, regulatory policies, and medical improvement.
Objective : This study seeks to gauge the general public’s understanding and perceived benefits, health concerns, and degree of confidence in the safety of nanoparticles in biomaterials. The public perception of the use of nanotechnology in healthcare will be assessed using a quantitative survey approach to analyze the relationship and impact of the aforementioned factors on the public’s confidence.
Methods : A descriptive cross-sectional study was developed using a survey administered to 250 subjects from various medical fields including professionals, engineers, and researchers, as well as total laymen. Participants were asked demographic questions and other questions about awareness, perceived benefits, health issues, and even their legislative opinions were collected through structured questionnaires. It was analyzed descriptively using central tendency and variability measures, relationships between variables via correlation analysis, regression modeling, reliability analysis, normality, and construct validity (Cronbach’s Alpha and Spearman-Brown tests). Shapiro-Wilk test was used for normality assessments.
Results: The responses given did not follow a normal distribution which is suggestive of varying perceptions among participants. The reliability scale calculated was very low for Cronbach’s Alpha (0.185) and Spearman-Brown’s coefficient (0.33) which indicates a lack of internal reliability. The correlation analysis indicated weak to moderate correlations between perceived benefits, risks, and regulatory issues. Multiple regression analysis showed that all independent variables failed to significantly predict the respondent’s confidence in the safety of the nanoparticles. The R-squared values were low suggesting that other factors had more influence on public impression than was analyzed.
Conclusion:This study analysis suggests that the public perception of the nanoparticles in biomaterials is vague and inconsistent making it difficult to communicate risks properly and provide a clearer education to the public regarding the regulation. The analysis shows that there is not much confidence among the public in the application of nanotechnology regardless of the benefits, risks, or regulations set but are influenced by media attendance and personal experiences. Further studies should improve the reliability of the survey, include more representative and larger samples, and investigate the issue with qualitative methods to understand better people’s attitudes towards nanotechnology in biomaterials
Downloads
References
[1] Aoki, K., & Saito, N. (2020). Biocompatibility and carcinogenicity of carbon nanotubes as biomaterials. Nanomaterials, 10(2), 264.
[2] Bapat, R. A., Chaubal, T. V., Dharmadhikari, S., Abdulla, A. M., Bapat, P., Alexander, A., Dubey, S. K., & Kesharwani, P. (2020). Recent advances of gold nanoparticles as a biomaterial in dentistry. International journal of pharmaceutics, 586, 119596.
[3] Baranowska-Wójcik, E., Szwajgier, D., Oleszczuk, P., & Winiarska-Mieczan, A. (2020). Effects of titanium dioxide nanoparticles exposure on human health—a review. Biological trace element research, 193, 118-129.
[4] Biswal, T., BadJena, S. K., & Pradhan, D. (2020). Sustainable biomaterials and their applications: A short review. Materials Today: Proceedings, 30, 274-282.
[5] Brokesh, A. M., & Gaharwar, A. K. (2020). Inorganic biomaterials for regenerative medicine. ACS applied materials & interfaces, 12(5), 5319-5344.
[6] Dai, H., Fan, Q., & Wang, C. (2022). Recent applications of immunomodulatory biomaterials for disease immunotherapy. Exploration,
[7] Dara, P. K., Mahadevan, R., Digita, P., Visnuvinayagam, S., Kumar, L. R., Mathew, S., Ravishankar, C., & Anandan, R. (2020). Synthesis and biochemical characterization of silver nanoparticles grafted chitosan (Chi-Ag-NPs): In vitro studies on antioxidant and antibacterial applications. SN Applied Sciences, 2, 1-12.
[8] de Menezes, B. R. C., Rodrigues, K. F., da Silva Fonseca, B. C., Ribas, R. G., do Amaral Montanheiro, T. L., & Thim, G. P. (2019). Recent advances in the use of carbon nanotubes as smart biomaterials. Journal of Materials Chemistry B, 7(9), 1343-1360.
[9] Dong, R., Liu, Y., Mou, L., Deng, J., & Jiang, X. (2019). Microfluidics‐based biomaterials and biodevices. Advanced Materials, 31(45), 1805033.
[10] Dong, R., Ma, P. X., & Guo, B. (2020). Conductive biomaterials for muscle tissue engineering. Biomaterials, 229, 119584.
[11] Foulkes, R., Man, E., Thind, J., Yeung, S., Joy, A., & Hoskins, C. (2020). The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives. Biomaterials science, 8(17), 4653-4664.
[12] Gaharwar, A. K., Singh, I., & Khademhosseini, A. (2020). Engineered biomaterials for in situ tissue regeneration. Nature Reviews Materials, 5(9), 686-705.
[13] Huang, H., Feng, W., & Chen, Y. (2021). Two-dimensional biomaterials: material science, biological effect, and biomedical engineering applications. Chemical Society Reviews, 50(20), 11381-11485.
[14] Kapat, K., Shubhra, Q. T., Zhou, M., & Leeuwenburgh, S. (2020). Piezoelectric nano‐biomaterials for biomedicine and tissue regeneration. Advanced Functional Materials, 30(44), 1909045.
[15] Khalilov, R. (2023). A COMPREHENSIVE REVIEW OF ADVANCED NANO-BIOMATERIALS IN REGENERATIVE MEDICINE AND DRUG DELIVERY. Advances in Biology & Earth Sciences, 8(1).
[16] Kumar, S., Nehra, M., Kedia, D., Dilbaghi, N., Tankeshwar, K., & Kim, K.-H. (2020). Nanotechnology-based biomaterials for orthopedic applications: Recent advances and prospects. Materials science and engineering: C, 106, 110154.
[17] Kumarage, V., Siriwardane, I., Sandaruwan, C., Kandanapitiya, M. S., Kottegoda, N., & Jayewardenepura, G. (2022). Nanotechnology Applications in Biomaterials; A review. J. Res. Technol. Eng, 3, 32-54.
[18] Lee, H. P., & Gaharwar, A. K. (2020). Light‐responsive inorganic biomaterials for biomedical applications. Advanced science, 7(17), 2000863.
[19] Liang, Y., Liang, Y., Zhang, H., & Guo, B. (2022). Antibacterial biomaterials for skin wound dressing. Asian Journal of Pharmaceutical Sciences, 17(3), 353-384.
[20] Ma, J., & Wu, C. (2022). Bioactive inorganic particles‐based biomaterials for skin tissue engineering. Exploration,
[21] Malakar, A., Kanel, S. R., Ray, C., Snow, D. D., & Nadagouda, M. N. (2021). Nanomaterials in the environment, human exposure pathway, and health effects: A review. Science of the Total Environment, 759, 143470.
[22] Mostafavi, E., Soltantabar, P., & Webster, T. J. (2019). Nanotechnology and biotechnology: a new arena for translational medicine. In Biomaterials in translational medicine (pp. 191-212). Elsevier.
[23] Mozafari, M. (2020). Nanoengineered biomaterials for advanced drug delivery. Elsevier.
[24] Muhammad, Q., Jang, Y., Kang, S. H., Moon, J., Kim, W. J., & Park, H. (2020). Modulation of immune responses with nanoparticles and reduction of their immunotoxicity. Biomaterials science, 8(6), 1490-1501.
[25] Punj, S., Singh, J., & Singh, K. (2021). Ceramic biomaterials: Properties, state of the art and prospects. Ceramics International, 47(20), 28059-28074.
[26] Qu, X., Yang, H., Yu, Z., Jia, B., Qiao, H., Zheng, Y., & Dai, K. (2020). Serum zinc levels and multiple health outcomes: implications for zinc-based biomaterials. Bioactive Materials, 5(2), 410-422.
[27] Su, Y., Cockerill, I., Wang, Y., Qin, Y.-X., Chang, L., Zheng, Y., & Zhu, D. (2019). Zinc-based biomaterials for regeneration and therapy. Trends in biotechnology, 37(4), 428-441.
[28] Suwardi, A., Wang, F., Xue, K., Han, M. Y., Teo, P., Wang, P., Wang, S., Liu, Y., Ye, E., & Li, Z. (2022). Machine learning‐driven biomaterials evolution. Advanced Materials, 34(1), 2102703.
[29] Wang, H., Xu, Z., Li, Q., & Wu, J. (2021). Application of metal-based biomaterials in wound repair. Engineered Regeneration, 2, 137-153.
[30] Wang, Y., Zhang, W., & Yao, Q. (2021). Copper-based biomaterials for bone and cartilage tissue engineering. Journal of Orthopaedic Translation, 29, 60-71.
[31] Yu, R., Zhang, H., & Guo, B. (2022). Conductive biomaterials as bioactive wound dressing for wound healing and skin tissue engineering. Nano-micro letters, 14, 1-46.
[32] Yue, S., He, H., Li, B., & Hou, T. (2020). Hydrogel as a biomaterial for bone tissue engineering: A review. Nanomaterials, 10(8), 1511.
[33] Zheng, Y., Hong, X., Wang, J., Feng, L., Fan, T., Guo, R., & Zhang, H. (2021). 2D nanomaterials for tissue engineering and regenerative nanomedicines: recent advances and future challenges. Advanced healthcare materials, 10(7), 2001743.
[34] Zou, Y., Huang, B., Cao, L., Deng, Y., & Su, J. (2021). Tailored mesoporous inorganic biomaterials: assembly, functionalization, and drug delivery engineering. Advanced Materials, 33(2), 2005215.
..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
